Best in Biotech 27 Jan 2025
Top 19 most-performing biotech stocks of 2024
Discover the top-performing biotech stocks in 2024 – from oncology to psychedelics some companies showed remarkable results.
investment
- Latest Posts
Podcast 17 Jan 2025
Venture capital co-creation: The next big thing in biotech investment?
This week, we talked with Jessica Owen, co-founder of Initiate Ventures, a venture firm with an interesting dual model.
In Depth 9 Jan 2025
Saudi Arabia: is the country set to become a global biotech hub?
In the last year or so, there have been a number of indications that Saudi Arabia is setting itself up to become a global biotech hub. Over the next decade, it is expected to become a world leader in biotech research and generate significant economic growth. The most recent indication of Saudi Arabia’s progress toward […]
In Depth 7 Jan 2025
The biggest private biotech investments in December 2024
The companies Nuvig Therapeutics, Ottimo Pharma, and Angitia Biopharmaceuticals bagged the biggest private biotech investments in December 2024.
Podcast 20 Dec 2024
Looking at 2025 biotech trends with SoftBank Vision Fund
In our discussion with John Cassidy from SoftBank Vision Fund, we cover investment trends within life sciences, the European health and biotech scene
In Depth 13 Dec 2024
Is China the future of biotech?
Delve into the ongoing transformation of China’s biotech industry in the last 10 years and in the future evolving geopolitical context.
ADVERTISEMENT
ADVERTISEMENT
More News! 10 Dec 2024
Biotech in 2024: A retrospective
2024 is coming to a close and it is time to look at how biotech performed this year. Was it a triumph or a year of cautious optimism?
Podcast 6 Dec 2024
Cracking the code of biotech valuations
Our guest on the podcast this week to discuss the biotech scene in Eastern Europe, and look at some of the challenges facing biotech companies is Adam Marťák, CEO of ambiom.
In Depth 5 Dec 2024
The biggest private biotech investments in November 2024
The companies Metsera, Alentis Therapeutics, and Adcendo bagged the biggest private biotech investments in November 2024.
In Depth 18 Nov 2024
What is Abcam’s founder, Jonathan Milner, up to?
Since Abcam was acquired in December 2023, its founder, Jonathan Milner has been very active. Delve into his investment strategy.
Expert Advice 15 Nov 2024
How biotech startups become unicorns
Delve into what differentiates a successful biotech startup from a unicorn reaching a $1 billion valuation.
Podcast 15 Nov 2024
Beyond profits: The Bill & Melinda Gates MRI’s mission to combat neglected diseases
This week, our guest is Dr Claire Wagner, head of corporate strategy and market access at the Bill & Melinda Gates Medical Research Institute (Gates MRI).
ADVERTISEMENT
